Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Eli Lilly (LLY -2.39%) received approval for Zepbound, a weight-management medicine, in November 2023
Injectables still define peak efficacy and platform confidenceespecially for next-gen combinations
Ozempic and Rybelsus are both approved by the US Food and Drug Administration (FDA) to treat adults with type 2 diabetes by controlling blood sugar levels
Interest accrues from day one
A drug with 28% mean weight loss can have very different commercial and clinical profiles depending on whether that mean is produced by a narrow cluster of super-responders or by broad consistent response across the enrolled population
US$ 21.46
US$ 28.57
US$ 24.26
US$ 22.19
US$ 24.46
